Methyldopa Bp Flamingo Pharma Uk (Methyldopa)

Methyldopa is converted in the liver to alpha‑methyldopamine, which activates central alpha‑2 adrenergic receptors. Stimulation of these receptors reduces sympathetic nervous system activity, leading to decreased norepinephrine release, lower heart rate, reduced peripheral vascular resistance, and ultimately a fall in blood pressure.

The appropriate dose of methyldopa is individualized by the prescribing clinician based on the patient’s blood pressure, response, and tolerability. Dosage adjustments are made during therapy to achieve target blood pressure while minimizing side effects.

Methyldopa is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no well‑controlled human studies. It is commonly used for pregnancy‑induced hypertension. Limited data are available for breastfeeding, so clinicians weigh benefits against potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with beta‑blockers or calcium‑channel blockers, methyldopa offers a centrally acting mechanism that is especially useful in pregnancy because of its safety profile. It may be less potent than some newer agents, requiring higher doses, but its long‑standing use and tolerability make it a valuable option in specific patient groups.

Methyldopa tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Methyldopa is taken orally, usually with food or a glass of water to reduce gastrointestinal irritation. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events include liver toxicity (hepatitis or elevated enzymes) and hemolytic anemia. Patients should be monitored for signs of jaundice, dark urine, fatigue, or unexplained bruising, and any concerning symptoms should prompt immediate medical evaluation.

Methyldopa is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in individuals with severe liver disease, active depression, or those taking monoamine oxidase inhibitors, as the risk of adverse reactions may be heightened.